Compare CVS & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVS | MDT |
|---|---|---|
| Founded | 1963 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Retail-Drug Stores and Proprietary Stores | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.7B | 131.9B |
| IPO Year | 1994 | 2014 |
| Metric | CVS | MDT |
|---|---|---|
| Price | $80.72 | $96.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 19 |
| Target Price | $94.33 | ★ $109.82 |
| AVG Volume (30 Days) | 7.2M | ★ 8.2M |
| Earning Date | 05-07-2026 | 05-19-2026 |
| Dividend Yield | ★ 3.31% | 2.94% |
| EPS Growth | N/A | ★ 30.80 |
| EPS | 1.39 | ★ 2.76 |
| Revenue | ★ $402,067,000,000.00 | $33,537,000,000.00 |
| Revenue This Year | $2.53 | $8.57 |
| Revenue Next Year | $4.78 | $5.86 |
| P/E Ratio | $58.01 | ★ $35.06 |
| Revenue Growth | ★ 7.85 | 3.62 |
| 52 Week Low | $58.35 | $79.55 |
| 52 Week High | $85.15 | $106.33 |
| Indicator | CVS | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 57.55 | 41.81 |
| Support Level | $76.72 | $94.46 |
| Resistance Level | $80.76 | $100.35 |
| Average True Range (ATR) | 2.08 | 2.07 |
| MACD | 0.55 | -0.26 |
| Stochastic Oscillator | 86.65 | 18.13 |
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.